ZhuoDao Medical Completes Series A Funding Round Led by Zhangjiang Hi-Tech and Lenovo Capital and Incubator

VCBeat has learned at the earliest opportunity that,Shanghai ZD Medical Technology Co., Ltd., a leading Chinese innovative enterprise in intelligent rehabilitation robotics (Abbreviation“ZD Medical^®”) completed tens of millions of yuan in Series A financing, led by Zhangjiang High-Tech and followed by Legend Star.It is understood that the funds raised in this round will be primarily used for the research, development, and registration of innovative rehabilitation robotics products; accelerating the expansion of the intelligent rehabilitation hardware product portfolio; market expansion; and brand building.

As an investor in this round, Dr. He Dajun, General Manager of Zhangjiang High-Tech, stated, “ZD Medical is an outstanding project incubated by Zhangjiang High-Tech’s incubator. The company targets the mid-to-high-end rehabilitation medical market, which boasts broad prospects. During the incubation process, we have been delighted to witness ZD Medical’s robust growth. Its team is vibrant, enterprising, and committed to independent R&D, having developed a competitive product portfolio. The products have successively obtained Class II medical device registration certificates and achieved significant sales volume. We believe that ZD Medical will grow into a rising star in the rehabilitation medical field, driving industry upgrades and benefiting a wide range of rehabilitation patients.”

Lu Gang, Partner at Legend Star, stated, “ZD Medical boasts a profound background in the integration of medicine and engineering, enabling it to deeply understand the pain points in clinical rehabilitation. The company possesses industry-leading capabilities in productization and clinical implementation. Furthermore, its young team is filled with entrepreneurial passion. Legend Star is highly optimistic about ZD Medical’s development prospects, as well as the industry outlook for the digital and intelligent transformation of the rehabilitation sector.”

The market size of rehabilitation medical devices in China is experiencing explosive growth, with continuous updates and iterations in the field. As a high-end rehabilitation medical technology, rehabilitation robots are the product of deep integration between robotics and medical technologies. They assist rehabilitation therapists in performing repetitive mechanical tasks and also enable remote and centralized rehabilitation services.

ZD Medical specializes in the research, development, and application of rehabilitation robots and intelligent rehabilitation solutions.Although established only five years ago, the company has made remarkably rapid progress in the field of rehabilitation robotics. Leveraging a core team with professional backgrounds in medical devices and over a decade of experience in R&D for rehabilitation robots and medical device project management, Shanghai ZD Medical Technology Co., Ltd. excels at deeply understanding and addressing clinical users’ needs. The company is adept at applying comprehensive engineering methodologies to solve complex medical problems, employing a systematic, framework-based software and hardware technology architecture to build reusable and scalable core technologies and functional modules. Committed to a user-centric approach, it provides reliable support to a broader range of patients and users.

In terms of product lines, the company has developed more than ten rehabilitation robots with globally leading technologies through continuous innovation.Among these, the Nimbot® upper-limb exoskeleton robot features the world’s first mechanically powered exoskeleton structure with a five-degree-of-freedom design for the shoulder complex, establishing it as an internationally leading benchmark product. The ArmGuider® upper-limb rehabilitation training system obtained the first Class II medical device registration certificate among similar domestic products and has been installed and applied in hundreds of hospitals across China. As the first innovative medical device in China to enable full-degree-of-freedom training for the hip and knee joints, the SmartSling® lower-limb rehabilitation training robot received its Class II medical device registration certificate at the end of 2020 and officially entered the market. Smart OT products such as the SmartColor® multi-sensory feedback electronic pegboard and the APTable™ intelligent sanding table break away from traditional rehabilitation paradigms, infusing modern rehabilitation with intelligence. Building on its commercially available products, Shanghai ZD Medical Technology Co., Ltd. is developing a comprehensive portfolio of intelligent rehabilitation medical devices, including 3D upper-limb rehabilitation training robots, fine motor skill training robots for the upper limbs, ankle-foot rehabilitation robots, supine systems, balance training systems, and perception and cognitive training systems.

ZD Medical Product Series Showcase

In addition to its robust product R&D foundation, ZD Medical has built a high-caliber team for channel development and market promotion within two years. With a nationwide presence, the team delivers professional and attentive services to customers. TodayThe company’s core products have been deployed in the rehabilitation medicine departments of over 300 top-tier hospitals and specialized rehabilitation hospitals across China, achieving high utilization rates and positive user feedback.Over the past five years, Shanghai ZD Medical Technology Co., Ltd. (Zhuodao Medical) has devoted substantial efforts to product research and development as well as market promotion. These areas will remain their key focus in the future. Meanwhile, by providing a comprehensive suite of rehabilitation solutions, they aim to transform traditional rehabilitation departments into intelligent units, thereby driving the gradual intelligentization of rehabilitation medicine and therapy.

In terms of scientific research and innovation, the company has secured dozens of patents and software copyrights, undertaken more than ten national, provincial/ministerial, and Central Military Commission projects, and drafted the national standard for upper-limb rehabilitation training robots. It serves as a founding council member of the Rehabilitation Robot Alliance under the Chinese Association of Rehabilitation Medicine (CARM), a founding committee member of the CARM Committee on Rehabilitation Engineering and Industry Promotion, and a founding committee member of the CARM Committee on Rehabilitation for Craniocerebral Trauma. The company was recognized as a High-Tech Enterprise in Shanghai in 2019 and was featured in an interview and report by CCTV’s “Xinwen Lianbo” (News Broadcast) in 2020.

Steady Progress for Long-Term Success: Over the past five years, ZD Medical has pioneered a viable path in the rehabilitation industry by leveraging independent R&D to equip robots with specialized therapeutic protocols. Looking ahead, ZD Medical will continue to delve deeply into user needs, providing intelligent solutions for rehabilitation medicine and therapy through robot-assisted technologies, smart software and hardware terminals, the Internet of Things (IoT), and big data. By serving patients across diverse scenarios, stages of recovery, and geographic regions, ZD Medical aims to enable more people to enjoy a higher quality of life guided by cutting-edge rehabilitation medical products.

Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. was officially listed on the Shanghai Stock Exchange in April 1996, with stock code: 600895. It is a key developer of Zhangjiang Science City. The company is actively responding to national strategic opportunities, engaging with global innovation resources, accelerating the aggregation of global innovation factors, and building an innovation ecosystem for Zhangjiang Science City. By creating full-lifecycle spatial carriers, it provides technology enterprises with industrial space solutions ranging from incubation and acceleration to R&D offices. By deploying investment funds across the entire industry chain, it leverages the venture capital function of state-owned enterprises through direct investment plus fund models to mobilize market resources and support enterprise development. By offering seamlessly connected innovation services, it gathers innovation resources to build an innovation service ecosystem.

Legend Star, founded in 2008, is one of the earliest venture capital firms to systematically position itself in the healthcare sector. Since 2010, Legend Star has designated healthcare as a key area for its investment focus. In this field, Legend Star’s strategic layout is centered on two major pillars: “New Technologies” and “New Services.” New Technologies encompass novel biologics and therapies, gene technologies and services, diagnostic technologies, and high-value consumables. New Services include diagnostic/data terminals deployable at the primary care level, innovations in healthcare service delivery, and optimization of medical resource allocation. To date, Legend Star has invested in over 100 high-quality healthcare projects.